P3 Health Partners Inc (NASDAQ:PIII) has a beta value of 0.96 and has seen 1.91 million shares traded in the last trading session. The company, currently valued at $37.46M, closed the last trade at $0.23 per share which meant it lost -$0.01 on the day or -3.77% during that session. The PIII stock price is -430.43% off its 52-week high price of $1.22 and 26.09% above the 52-week low of $0.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.57 million shares traded. The 3-month trading volume is 2.30 million shares.
The consensus among analysts is that P3 Health Partners Inc (PIII) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
P3 Health Partners Inc (NASDAQ:PIII) trade information
Sporting -3.77% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PIII stock price touched $0.23 or saw a rise of 7.59%. Year-to-date, P3 Health Partners Inc shares have moved 2.27%, while the 5-day performance has seen it change 17.35%. Over the past 30 days, the shares of P3 Health Partners Inc (NASDAQ:PIII) have changed 9.52%. Short interest in the company has seen 2.23 million shares shorted with days to cover at 0.42.
P3 Health Partners Inc (PIII) estimates and forecasts
The company’s shares have lost -61.02% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 19.13%.
4 analysts offering their estimates for the company have set an average revenue estimate of 378.88M for the current quarter. 1 have an estimated revenue figure of 375.8M for the next ending quarter. Year-ago sales stood 346.86M and 388.49M respectively for this quarter and the next, and analysts expect sales will grow by 9.23% for the current quarter and 19.13% for the next.
Earnings growth for 2025 is a modest 11.11% while over the next 5 years, the company’s earnings are expected to increase by 12.64%.
PIII Dividends
P3 Health Partners Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
Insiders own 62.32% of the company shares, while shares held by institutions stand at 13.07% with a share float percentage of 34.68%. Investors are also buoyed by the number of investors in a company, with P3 Health Partners Inc having a total of 42.0 institutions that hold shares in the company. The top two institutional holders are ALYESKA INVESTMENT GROUP, L.P. with over 15.95 million shares worth more than $7.18 million. As of 2024-06-30, ALYESKA INVESTMENT GROUP, L.P. held 13.4152% of shares outstanding.
The other major institutional holder is ARMISTICE CAPITAL, LLC, with the holding of over 7.9 million shares as of 2024-06-30. The firm’s total holdings are worth over $3.56 million and represent 6.645% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 0.89% shares in the company for having 1.45 shares of worth $0.33 million while later fund manager owns 473.5 shares of worth $0.11 million as of Nov 30, 2024 , which makes it owner of about 0.29% of company’s outstanding stock.
